Feb 21 (Reuters) - Proteomics International Laboratories Ltd PIQ.AX :
* GRANTED A PATENT IN UNITED STATES FOR USE OF ONE OF CORE PROMARKERD BIOMARKERS AS A POTENTIAL DRUG TARGET
Feb 21 (Reuters) - Proteomics International Laboratories Ltd PIQ.AX :
* GRANTED A PATENT IN UNITED STATES FOR USE OF ONE OF CORE PROMARKERD BIOMARKERS AS A POTENTIAL DRUG TARGET